Skip to main content
OpenTrials
Completed

NCT Number: NCT04341974

Perioperative Use of Serum Creatinine and Postoperative Acute Kidney Injury

The perioperative approach adopted in a cohort of adult oncological patients undergoing major abdominal surgery will be described. In particular, the physician's attitude toward use of sCr for identification of patients at risk for PO-AKI will be described, as well as the patients who should be reassessed in the long term for progression toward CKD. The incidence and risk factors associated with PO-AKI and renal function deterioration within a year postoperatively will be also evaluated.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Azienda Ospedaliero Universitaria Careggi

Florence, 50100, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients
  • Scheduled for elective surgery
  • Surgery for oncological disease

Exclusion criteria

  • Patients undergoing postoperative chemotherapy
  • Patients who died within 12 month after surgery

Treatment and study plan

serum creatinine

Diagnostic Test

Will be described: 1) the number of patients actually screened with postoperative serum creatinine and 2) the number of patients actually screened with the same parameter at the long-term after surgery

Primary outcomes

  1. Adoption of serum creatinine as marker of acute kidney injury postoperively

    Time frame: 3rd postoperative day

    Number of actual patients screened postoperatively

Secondary outcomes

  1. Incidence of acute kidney injury

    Time frame: 3rd postoperative day

    Number of patients with a postoperative diagnostic increase of serum creatinine, in accordance with KDIGO guidelines

  2. Adoption of serum creatinine as marker of long term kidney dysfunction

    Time frame: 12 month after surgery

    Number of actual patients screened at the long term

  3. Incidence of long term kidney dysfunction

    Time frame: 12 month after surgery

    Number of patients with a long term reduction in GFR greater than 10 ml/min with respect to the baseline

Sponsors and collaborators

Lead sponsor

Careggi Hospital

Other

Registry information

Official study title

Perioperative Use of Serum Creatinine and Postoperative Acute Kidney Injury: an Observational, Monocentric, Retrospective Study to Explore Physicians' Perception and Practice.

Acronym: CreaPeriop

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Apr 10, 2020
Registry last updated
Apr 14, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.